Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4607]

Preclinical trials of anti-AXL agent increase sensitivity to radiation and check-point inhibitors

Preclinical trials of anti-AXL agent increase sensitivity to radiation and check-point inhibitors

First genomics-driven model for personalised radiation therapy

First genomics-driven model for personalised radiation therapy

New test could detect ovarian cancer patients who are strongly responding to treatment

New test could detect ovarian cancer patients who are strongly responding to treatment

Cure or cause? Mixed messages for NSAIDs, including aspirin

Cure or cause? Mixed messages for NSAIDs, including aspirin

FDA grants accelerated approval to rucaparib for advanced ovarian cancer

FDA grants accelerated approval to rucaparib for advanced ovarian cancer

Asian head and neck cancer patients live longer with immunotherapy than mixed race group

Asian head and neck cancer patients live longer with immunotherapy than mixed race group

Asian head and neck cancer patients live longer with immunotherapy than mixed race group

Asian head and neck cancer patients live longer with immunotherapy than mixed race group

Tumour gene test results can differ in same patients

Tumour gene test results can differ in same patients

Common breast cancer mutation could be vulnerable to drug combination

Common breast cancer mutation could be vulnerable to drug combination

Almost 20 percent of breast cancer patients fail to complete prescribed endocrine therapy

Almost 20 percent of breast cancer patients fail to complete prescribed endocrine therapy

More from ecancer